Abingem 200mg Injection
Marketer
Miracalus Pharma Pvt Ltd
Salt Composition
Gemcitabine (200mg)
Overview Abingem 200mg Injection
Gemcitabine 200mg Injection treats several cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe complications. Therapeutic effects may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include nausea, vomiting, anorexia, alopecia, and thrombocytopenia. This medication can reduce blood cell counts, increasing infection risk, necessitating regular blood tests monitoring blood cell levels, along with heart, liver, and uric acid function. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent medications, particularly anti-infectives, before treatment. Interactions with other drugs are possible; disclose all medications. Avoid pregnancy during treatment; both partners should use effective contraception.
Uses of Abingem 200mg Injection
Lung cancer (excluding small cell types)|Breast malignancy|Pancreatic adenocarcinoma|Bladder cancer|Ovarian neoplasm
Major Benefits of Abingem 200mg Injection:
Administering this medication requires a healthcare professional; it must be given by your doctor or nurse.
Common Side effects of Abingem 200mg Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Abingem 200mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Abingem 200mg Injection works:
Abingem 200mg Injection halts cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of their fundamental components. This action effectively inhibits the growth and replication of cancerous cells.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Abingem 200mg Injection and alcohol may result in significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Abingem 200mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions may exist in critical medical emergencies where the potential benefits outweigh the known hazards, at the physician's sole discretion. Physician consultation is essential.
Breast feedingUNSAFE
The administration of Abingem 200mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
The administration of Abingem 200mg Injection can lead to reduced alertness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Abingem 200mg Injection use in individuals with renal impairment. Physician consultation is necessary. Pre-treatment kidney function assessment is recommended, along with ongoing monitoring post-treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Abingem 200mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Abingem 200mg Injection :
NA
Facts to Know About Abingem 200mg Injection
| Label | Value |
|---|---|
| Chemical Category | Cytosine Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Metabolic Inhibitors |
3,018 People bought this recently